Allergy-blocking nasal spray is safe

Israel’s Polyrizon (see here previously) announced the successful preliminary safety study for a formulation of its PL-14 Allergy Blocker, marking a significant advancement in the product’s development path.

https://www.nasdaq.com/articles/polyrizon-ltd-announces-successful-preliminary-safety-study-pl-14-allergy-blocker

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *